Beclabuvir

Beclabuvir
Legal status
Legal status
  • Investigational New Drug
Identifiers
Synonyms BMS-791325
CAS Number 958002-33-0
PubChem (CID) 56934415
ChemSpider 27289076
UNII MYW1X5CO9S YesY
Chemical and physical data
Formula C36H45N5O5S
Molar mass 659.84 g/mol
3D model (Jmol) Interactive image

Beclabuvir (BMS-791325) is an antiviral drug for the treatment of hepatitis C virus (HCV) infection currently in clinical trials. Beclabuvir acts as a NS5B inhibitor.[1]

References

  1. Tatum, H.; Thuluvath, P. J.; Lawitz, E.; Martorell, C.; DeMicco, M.; Cohen, S.; Rustgi, V.; Ravendhran, N.; Ghalib, R.; Hanson, J.; Zamparo, J.; Zhao, J.; Cooney, E.; Treitel, M.; Hughes, E. (December 2014). "A randomized, placebo-controlled study of the NS5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1". Journal of Viral Hepatitis: n/a–n/a. doi:10.1111/jvh.12372.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.